Evaluation and construction of diagnostic criteria for inclusion body myositis
about
Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementEmerging therapeutic options for sporadic inclusion body myositisA computational framework for converting textual clinical diagnostic criteria into the quality data modelSarcoidosis: Is It a Possible Trigger of Inclusion Body Myositis?Immune and myodegenerative pathomechanisms in inclusion body myositisTargeted sequencing and identification of genetic variants in sporadic inclusion body myositis.PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune DiseasesT-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.Developing a modular architecture for creation of rule-based clinical diagnostic criteria.Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.Tdp-43 cryptic exons are highly variable between cell types.Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.Neuromuscular issues in systemic disease.Myositis Mimics.Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.Muscle imaging in inherited and acquired muscle diseases.Diagnostic criteria for inclusion body myositis.Association study reveals novel risk loci for sporadic inclusion body myositis.Integrated classification of inflammatory myopathies.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis.2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.Cytokine Profiling of Serum Allows Monitoring of Disease Progression in Inclusion Body Myositis.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Inclusion body myositis pathogenesis: Steady progress.Current Classification and Management of Inflammatory Myopathies.New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis.
P2860
Q26744705-CEA162CB-5ED5-4C6D-A1D2-D92537CBE0CDQ26786571-77F85340-22B7-463A-94B0-5575A72311CAQ31116558-75301A57-46A1-4133-AD96-328A19B6F384Q33646319-114A8B38-741A-4996-A181-0BD29394519CQ33753870-643D981D-FA4B-4F6A-B793-F770307A321EQ35213944-28EC3F7B-245B-4312-9A3B-3711D9347A1AQ36788809-1DFFEC33-1B16-4F15-A8C4-062CCF7CB0C8Q36953554-6DC676F9-94BC-4C02-A8AC-7C6190E15587Q37228223-33C1A72A-E30F-40AD-BA3B-2E6FD7C6C565Q37356809-50A98B72-95D0-476E-B6A6-37B489C66927Q37562794-8CCD8536-1E49-4B6D-B840-8A676EB8BB60Q37621005-2035EDCE-0DBA-4A6A-B28F-481F52302B90Q38314711-AB3AA63D-6AA5-49BA-83CE-192BA8876A45Q38501865-24CD770F-B6C5-4FFD-AEC5-67437A0AF291Q38569863-07DE09F5-C0AC-4004-BFA8-B50DAEE35A3DQ38767200-1FEC1332-6B7B-4938-9BE9-3BAABC19E74EQ38784024-2C2306ED-CB63-402C-9536-87D7BD009190Q38793315-99CDA981-D26D-4919-9507-F2CE52E94A82Q38944635-6C000AEF-E057-432C-86AA-B1E7A41D6E1CQ39027323-AF0DB0F1-337F-4FBE-B974-A6A3357B22C0Q42365042-95622036-0036-4D41-A611-5941841B503DQ47148016-1A32F6FB-8F14-4047-9C85-364D794D3920Q47653276-C6BC99DD-0731-4189-8313-53A9D0E0C1CEQ47699498-21D34D1F-B0D2-49A3-A01C-0E485C5A84C3Q48539566-31CD7E5C-8C35-494E-8C58-0E26B477F507Q52597638-94DA5D49-D860-4B09-979C-4B529F4A47B3Q54645632-47A6674A-443C-4FB6-A1E3-BB70CDF39E8FQ54977148-701C3372-8BAF-45C5-A35E-9E39F2533A43Q55277507-8F7DC467-B61B-4405-AEB9-5434F1DDF317Q55322436-A0DBE021-A55F-4EAF-B502-84865EB8B0D4
P2860
Evaluation and construction of diagnostic criteria for inclusion body myositis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation and construction of diagnostic criteria for inclusion body myositis
@ast
Evaluation and construction of diagnostic criteria for inclusion body myositis
@en
Evaluation and construction of diagnostic criteria for inclusion body myositis
@nl
type
label
Evaluation and construction of diagnostic criteria for inclusion body myositis
@ast
Evaluation and construction of diagnostic criteria for inclusion body myositis
@en
Evaluation and construction of diagnostic criteria for inclusion body myositis
@nl
prefLabel
Evaluation and construction of diagnostic criteria for inclusion body myositis
@ast
Evaluation and construction of diagnostic criteria for inclusion body myositis
@en
Evaluation and construction of diagnostic criteria for inclusion body myositis
@nl
P2093
P2860
P1433
P1476
Evaluation and construction of diagnostic criteria for inclusion body myositis
@en
P2093
Andrew L Mammen
Anthony A Amato
Merrilee Needham
Michael D Weiss
Steven A Greenberg
P2860
P304
P356
10.1212/WNL.0000000000000642
P407
P577
2014-06-27T00:00:00Z